99% Savings - Buy Just @1 Rs X
Symbiva 200 Octacap is a prescription medicine that is available as a Capsule. Asthma are some of its major therapeutic uses. Other than this, Symbiva 200 Octacap has some other therapeutic uses, which have been discussed ahead.
The right dosage of Symbiva 200 Octacap depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Symbiva 200 Octacap also has some side effects, the most common being Nasopharyngitis, Headache, Back Pain. Besides the aforementioned side effects, there are other adverse effects of Symbiva 200 Octacap as well, which are listed below. Usually, these side effects of Symbiva 200 Octacap go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Symbiva 200 Octacap has a Moderate effect for pregnant women and Moderate effect on lactating mothers. Further, the section on Symbiva 200 Octacap related warnings talks about Symbiva 200 Octacap's effects on the liver, heart and kidney.
Some other conditions that can be affected by Symbiva 200 Octacap are listed in the contraindications section below.
Additionally, Symbiva 200 Octacap may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Symbiva 200 Octacap is safe while driving, and is is addictive in nature.
Symbiva 200 Octacap is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Symbiva 200 Octacap safe for pregnant women?
Symbiva may have some side effects during pregnancy. Pregnant women should discontinue the use of Symbiva, and talk to their doctor, if they notice any discomfort.
Is the use of Symbiva 200 Octacap safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Symbiva. Immediately discontinue Symbiva if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Symbiva 200 Octacap on the Kidneys?
Symbiva does not damage the kidneys.
What is the effect of Symbiva 200 Octacap on the Liver?
Symbiva is not harmful for the liver.
What is the effect of Symbiva 200 Octacap on the Heart?
Symbiva may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Symbiva 200 Octacap unless your doctor advises you to do so -
Is this Symbiva 200 Octacap habit forming or addictive?
Symbiva 200 Octacap is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Symbiva 200 Octacap since it will not make you feel sleepy.
Is it safe?
Yes, but consume Symbiva 200 Octacap only on doctor's advice.
Is it able to treat mental disorders?
Symbiva 200 Octacap is unable to treat or cure mental disorders.
Interaction between Food and Symbiva 200 Octacap
Taking Symbiva 200 Octacap with food does not harm your health.
Interaction between Alcohol and Symbiva 200 Octacap
Taking Symbiva 200 Octacap with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Perforomist® (formoterol fumarate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 595-596
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 356-366
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Entocort® Ec (budesonide)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pulmicort Respules™ (budesonide)
Product Description [Internet]: SYMBICORT. AstraZeneca